Risk factors and the progression of thyroid malignancies

Hellenic Journal of Nuclear Medicine

Volumn 18, Issue 3, 2015, Pages 275-284

  Giannoula, E ^a   Iakovou, I ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; RISK FACTOR; THYROID CANCER; AGE DISTRIBUTION; DISEASE COURSE; FEMALE; HUMAN; INTERNATIONAL COOPERATION; META ANALYSIS; MORTALITY; PREVALENCE; RADIATION EXPOSURE; SEX RATIO; STATISTICS AND NUMERICAL DATA; SURVIVAL; THYROID TUMOR;

AGE DISTRIBUTION; DISEASE PROGRESSION; FEMALE; HUMANS; INTERNATIONALITY; PREVALENCE; RADIATION EXPOSURE; RISK FACTORS; SEX DISTRIBUTION; SURVIVAL ANALYSIS; THYROID NEOPLASMS;

EID: 84949504758     PISSN: 17905427     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. World Health Organization. International Agency for Research on Cancer. Globocan 2012: Estimated Cancer Incidence, Mortality and Prevalence Worldwide in 2012. Accessed February 7, 2015. Available at: http://globocan. iarc. fr /Pages/fact-sheets- cancer. aspx.
2. Kilfoy BA, Zheng T, Holford TR et al. International patterns and trends in thyroid cancer incidence, 1973-2002. Cancer Causes and Control 2009; 20(5): 525-31.
3. Davies L, Welch HG. Increasing incidence of thyroid cancer in the United States, 1973-2002. JAMA 2006; 295: 2164-7.
4. Cramer JD, Fu P, Harth KC et al. Analysis of the rising incidence of thyroid cancer using the Surveillance, Epidemiology and E nd Results national cancer data registry. Surgery 2010; 148(6): 1147-52.
5. Chen AY, Jemal A, Ward EM. Increasing incidence of differentiated thyroid cancer in the United States, 1988-2005. Cancer 2009; 115(16): 3801-7.
6. Aschebrook-Kilfoy B, Kaplan EL, Chiu BC et al. The acceleration in papillary thyroid cancer incidence rates is similar among racial and ethnic groups in the United States. Ann Surg Oncol 2013; 20(8): 2746-53.
7. Pellegriti G, Frasca F, Regalbuto C et al. Worldwide increasing incidence of thyroid cancer: update on epidemiology and risk factors. J Cancer Epidemiol 2013; 2013: 965212.
8. American Cancer Society. Thyroid Cancer Survival by Type and Stage. Accessed March 18, 2015. Available at: http://www. cancer. org/cancer/thyroidcancer/detailedguide/thyroid-cancersurvival-rates.
9. Choi H, Lim JA, Ahn HY et al. Secular trends in the prognostic factors for papillary thyroid cancer. Eur J Endocrinol 2014; 171 (5): 667-75.
10. Tran K, Khan S, Taghizadehasl M, et al. Gallium-68 Dotatate PE T/CT is superior to other imaging modalities in the detection of medullary carcinoma of the thyroid in the presence of high serum calcitonin. Hell J Nucl Med 2015; 18(1): 19-24.
11. He X, Wang X, Yu J, Ma C. Is it practical and cost Effective to detect differentiated thyroid carcinoma metastases by F-FD G PET/CT, by F-FDG SPET/CT -r by -I SPET/CT? Hell J Nucl Med 2015;18(1): 2-4.
12. Xu YH, Shen CT, Xue YL, et al. Iodine-131 SPET/CT and F-FD G PET/CT for the identification and localization of mediastinal lymph node metastases from differentiated thyroid carcinoma. Hell J Nucl Med 2013; 16(3): 199-203.
13. Kent WD, Hall SF, Isotalo PA et al. Increased incidence of differentiated thyroid carcinoma and detection of subclinical disease. CMAJ 2007; 177(11): 1357-61.
14. Hall SF, Irish J, Groome P, Gri-ths R. Access, excess, and overdiagnosis: the case for thyroid cancer. Cancer Med 2014; 3(1): 154-61.
15. Enewold L, Zhu K, Ron E et al. Rising thyroid cancer incidence in the United States by demographic and tumor characteristics, 1980-2005. Cancer Epidemiol Biomarkers Prev 2009; 18(3): 784-91.
16. Leux C, Guénel P. Risk factors of thyroid tumors: role of environmental and occupational exposures to chemical pollutants. Rev Epidemiol Sante Publique 2010; 58(5): 359-67.
17. Ermak G, Figge JJ, Kartel NA, Davies KJ. Genetic aberrations in Chernobyl-related thyroid cancers: implications for possible future nuclear accidents or nuclear attacks. IUBMB Life 2003; 55(12): 637-41.
18. Moysich KB, Menezes RJ, Michalek AM. Chernobyl-related ionising radiation exposure and cancer risk: an epidemiological review. Lancet Oncol 2002; 3(5): 269-79.
19. Simões-Pereira J, Vieira MS, Pereira MC. Latency Period until the Development of Thyroid Cancer in Young Patients Submitted to Radiotherapy: Report of 10 Cases. Case Rep Oncol 2014; 7(3): 810-4.
20. Ron E, Lubin JH, Shore RE et al. Thyroid cancer after exposure to external radiation: a pooled analysis of seven studies. Radiat Res 1995; 141(3): 259-77.
21. Mettler FA Jr, Bhargavan M, Thomadsen BR et al. Nuclear medicine exposure in the United States, 2005-2007: preliminary results. Semin Nucl Med 2008; 38(5): 384-91.
22. Williams D. Radiation carcinogenesis: lessons from Chernobyl. Oncogene 2008; 27 Suppl 2: S9-18.
23. Brenner AV, Tronko MD, Hatch M et al. I-131 dose response for incident thyroid cancers in Ukraine related to the Chornobyl accident. Environ Health Perspect 2011; 119(7): 933-9.
24. Goyal N, Camacho F, Mangano J, Goldenberg D. Evaluating for a geospatial relationship between radon levels and thyroid cancer in Pennsylvania. Laryngoscope 2015; 125(1): E45-9.
25. Sarika L, Papathoma A, Garofalaki M et al. Genetic screening of patients with Medullary Thyroid Cancer (MTC) in a referral center in Greece during the past two decades. Eur J Endocrinol 2015; 172(4): 501-9.
26. Huang CJ, Jap TS. A systematic review of genetic studies of thyroid disorders in Taiwan. J Chin Med Assoc 2015; 78(3): 145-53.
27. Han SA, Park WS, Jang JH et al. BRAF mutation may predict higher necessity of postoperative radioactive iodine ablation in papillary thyroid cancer. Ann Surg Treat Res 2014; 87(4): 17 4-9.
28. Haymart MR, Repplinger DJ, Leverson GE et al. Higher serum thyroid stimulating hormone level in thyroid nodule patients is associated with greater risks of differentiated thyroid cancer and advanced tumor stage. J Clin Endocrinol Metab 2008; 93(3): 809-14.
29. Liu CL, Cheng SP, Lin HW, Lai YL. Risk of thyroid cancer in patients with thyroiditis: a population-based cohort study. Ann Surg Oncol 2014; 21(3): 843-9.
30. American Thyroid Association (ATA) Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid Cancer, Cooper DS, Doherty GM, Haugen BR et al. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 2009; 19(11): 1167-214.
31. Dal Maso L, Bosetti C, La Vecchia C, Franceschi S. Risk factors for thyroid cancer: an epidemiological review focused on nutritional factors. Cancer Causes Control 2009; 20(1): 75-86.
32. Wolin KY, Carson K, Colditz GA. Obesity and cancer. Oncologist 2010; 15(6): 556-65.
33. Ma J, Huang M, Wang L, Ye W et al. Obesity and risk of thyroid cancer: evidence from a meta-analysis of 21 observational studies. Med Sci Monit 2015; 21: 283-91.
34. Almquist M, Johansen D, Björge T et al. Metabolic factors and risk of thyroid cancer in the Metabolic syndrome and Cancer project (Me-Can). Cancer Causes Control 2011; 22(5): 743-51.
35. Sakoda LC, Horn-Ross PL. Reproductive and menstrual history and papillary thyroid cancer risk: the San Francisco Bay Area thyroid cancer study. Cancer Epidemiol Biomarkers Prev 20 02; 11(1): 51-7.
36. Duntas LH, Doumas C. The 'rings of -re' and thyroid cancer. Hormones (Athens) 2009; 8(4): 249-53.
37. Chen B, Kan H. Air pollution and population health: a global challenge. Environ Health Prev Med 2008; 13(2): 94-101.
38. Boas M, Main KM, Feldt-Rasmussen U. Environmental chemicals and thyroid function: an update. Curr Opin Endocrinol Diabetes Obes 2009; 16(5): 385-91.
39. Freire C, Koifman RJ, Sarcinelli PN et al. Long-term exposure to organochlorine pesticides and thyroid status in adults in a heavily contaminated area in Brazil. Environ Res 2013; 127: 7-15.
40. Capen CC. Mechanistic data and risk assessment of selected toxic end points of the thyroid gland. Toxicol Pathol 1997; 25 (1): 39-48.
41. Marcello MA, Malandrino P, Almeida JF et al. The influence of the environment on the development of thyroid tumors: a new appraisal. Endocr Relat Cancer 2014; 21(5): T235-54.
42. Langer P, Tajtáková M, Kocan A et al. Thyroid ultrasound volume, structure and function after long-term high exposure of large population to polychlorinated biphenyls, pesticides and dioxin. Chemosphere 2007; 69(1): 118-27.
43. Grimalt JO, Sunyer J, Moreno V et al. Risk excess of soft-tissue sarcoma and thyroid cancer in a community exposed to airborne organochlorinated compound mixtures with a high hexachlorobenzene content. Int J Cancer 1994; 56(2): 200-3.
44. Yuspa SH, Shields PG. Etiology and Epidemiology of Cancer. Chemical Factors. In DeVita VT Jr, Lawrence TS, Rosenberg SA th Eds. Cancer: Principles and Practice of Oncology, 10 edn. Philadelphia: Lippincott Williams & Wilkins. 2014; 203-07.
45. Jemal A, Siegel R, Ward E et al. Cancer statistics, 2009. CA Cancer J Clin 2009; 59(4): 225-49.
46. Pellegriti G, De Vathaire F, Scollo C et al. Papillary thyroid cancer incidence in the volcanic area of Sicily. J Natl Cancer Inst 2009; 101(22): 1575-83.
47. Koedrith P, Kim H, Weon JI, Seo YR. Toxicogenomic approaches for understanding molecular mechanisms of heavy metal mutagenicity and carcinogenicity. Int J Hyg Environ Health 2013; 216(5): 587-98.
48. Rana SV. Perspectives in endocrine toxicity of heavy metals-a review. Biol Trace Elem Res 2014; 160(1): 1-14.